These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25369272)

  • 1. Modulation of TNF-α, TNF-α receptors and IL-6 after treatment with AM3 in professional cyclists.
    Córdova A; Sureda A; Pons A; Alvarez-Mon M
    J Sports Med Phys Fitness; 2015 Apr; 55(4):345-51. PubMed ID: 25369272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of AM3 (Inmunoferon) on increased serum concentrations of interleukin-6 and tumour necrosis factor receptors I and II in cyclists.
    Cordova A; Monserrat J; Villa G; Reyes E; Soto MA
    J Sports Sci; 2006 Jun; 24(6):565-73. PubMed ID: 16608770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against muscle damage in competitive sports players: the effect of the immunomodulator AM3.
    Córdova A; Martin JF; Reyes E; Alvarez-Mon M
    J Sports Sci; 2004 Sep; 22(9):827-33. PubMed ID: 15513276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AM3 (Inmunoferón) as an adjuvant to hepatitis B vaccination in hemodialysis patients.
    Pérez-García R; Pérez-García A; Verbeelen D; Bernstein ED; Villarrubia VG; Alvarez-Mon M
    Kidney Int; 2002 May; 61(5):1845-52. PubMed ID: 11967036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with AM3 restores defective T-cell function in COPD patients.
    Reyes E; Prieto A; de la Hera A; de Lucas P; Alvarez-Sala R; Alvarez-Sala JL; Alvarez-Mon M
    Chest; 2006 Mar; 129(3):527-35. PubMed ID: 16537848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity reversal by immunomodulation with oral AM3.
    Villarrubia VG; Moreno Koch MC; Calvo C; González S; Alvarez-Mon M
    Immunopharmacol Immunotoxicol; 1997 Feb; 19(1):53-74. PubMed ID: 9049659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with the immunomodulator AM3 improves the health-related quality of life of patients with COPD.
    Alvarez-Mon M; Miravitlles M; Morera J; Callol L; Alvarez-Sala JL
    Chest; 2005 Apr; 127(4):1212-8. PubMed ID: 15821197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoferon, a glycoconjugate of natural origin, inhibits LPS-induced TNF-alpha production and inflammatory responses.
    Brieva A; Guerrero A; Alonso-Lebrero JL; Pivel JP
    Int Immunopharmacol; 2001 Oct; 1(11):1979-87. PubMed ID: 11606029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AM3 inhibits HBV replication through activation of peripheral blood mononuclear cells.
    Majano P; Roda-Navarro P; Alonso-Lebrero JL; Brieva A; Casal C; Pivel JP; López-Cabrera M; Moreno-Otero R
    Int Immunopharmacol; 2004 Jul; 4(7):921-7. PubMed ID: 15182731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AM3 inhibits LPS-induced iNOS expression in mice.
    Majano P; Alonso-Lebrero JL; Janczyk A; Martín-Vichez S; Molina-Jiménez F; Brieva A; Pivel JP; González S; López-Cabrera M; Moreno-Otero R
    Int Immunopharmacol; 2005 Jul; 5(7-8):1165-70. PubMed ID: 15914321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of AM3 in the resolution of otitis media with effusion (OME) in paediatric patients].
    Ortega del Alamo P; Rivera Rodríguez T; Sanz Fernández R
    Acta Otorrinolaringol Esp; 2005 Jan; 56(1):1-5. PubMed ID: 15747716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
    Sanoobar M; Eghtesadi S; Azimi A; Khalili M; Khodadadi B; Jazayeri S; Gohari MR; Aryaeian N
    Nutr Neurosci; 2015 May; 18(4):169-76. PubMed ID: 24621064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGN.
    Serrano-Gómez D; Martínez-Nuñez RT; Sierra-Filardi E; Izquierdo N; Colmenares M; Pla J; Rivas L; Martinez-Picado J; Jimenez-Barbero J; Alonso-Lebrero JL; González S; Corbí AL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2313-23. PubMed ID: 17452477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine response to strenuous exercise in athletes and non-athletes--an adaptive response.
    Gokhale R; Chandrashekara S; Vasanthakumar KC
    Cytokine; 2007 Nov; 40(2):123-7. PubMed ID: 17950614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor-alpha levels in men.
    Gökbel H; Gergerlioğlu HS; Okudan N; Gül I; Büyükbaş S; Belviranli M
    J Med Food; 2010 Feb; 13(1):216-8. PubMed ID: 20136458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
    González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
    Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inmunoferon, an immunomodulator of natural origin, does not affect the rat liver cytochrome P-450 and phase II conjugation enzymes.
    Brieva A; Guerrero A; Pivel JP
    Methods Find Exp Clin Pharmacol; 2003 Apr; 25(3):187-91. PubMed ID: 12743622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis.
    Albillos A; Nieto M; Ubeda M; Muñoz L; Fraile B; Reyes E; Lledó L; Blanco I; Pastor O; Salas C; Lario M; Monserrat J; Bataller R; Alvarez-Mon M
    Gut; 2010 Jul; 59(7):943-52. PubMed ID: 20442198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Tongmai decoction on the perioperative changes of plasma TNF-alpha and IL-6 in patients with femoral fractures].
    Wu ZJ; Zhao WL; Zeng YH; Zhu YZ; Ou JY
    Zhongguo Gu Shang; 2010 Jul; 23(7):500-3. PubMed ID: 20701121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of interleukin-6 and attenuation of tumor necrosis factor-α during wheelchair half marathon in athletes with cervical spinal cord injuries.
    Ogawa T; Nakamura T; Banno M; Sasaki Y; Umemoto Y; Kouda K; Kawasaki T; Tajima F
    Spinal Cord; 2014 Aug; 52(8):601-5. PubMed ID: 24891006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.